SJS Investment Consulting’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-21
| Closed | -$1.49K | – | 1569 |
|
|
2025
Q1 | $1.49K | Buy |
21
+17
| +425% | +$1.2K | ﹤0.01% | 852 |
|
|
2024
Q4 | $263 | Sell |
4
-24
| -86% | -$1.58K | ﹤0.01% | 1422 |
|
|
2024
Q3 | $1.97K | Buy |
28
+10
| +56% | +$703 | ﹤0.01% | 793 |
|
|
2024
Q2 | $1.48K | Sell |
18
-1
| -5% | -$82 | ﹤0.01% | 865 |
|
|
2024
Q1 | $1.66K | Buy |
19
+3
| +19% | +$262 | ﹤0.01% | 833 |
|
|
2023
Q4 | $1.54K | Sell |
16
-6
| -27% | -$579 | ﹤0.01% | 776 |
|
|
2023
Q3 | $1.95K | Buy |
22
+2
| +10% | +$177 | ﹤0.01% | 643 |
|
|
2023
Q2 | $1.73K | Buy |
20
+6
| +43% | +$520 | ﹤0.01% | 662 |
|
|
2023
Q1 | $1.36K | Sell |
14
-9
| -39% | -$876 | ﹤0.01% | 747 |
|
|
2022
Q4 | $2.38K | Buy |
23
+10
| +77% | +$1.04K | ﹤0.01% | 556 |
|
|
2022
Q3 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 632 |
|
|
2022
Q1 | $0 | Buy |
+3
| New | – | ﹤0.01% | 753 |
|